| Product NDC: | 0338-6010 |
| Proprietary Name: | Milrinone Lactate in Dextrose |
| Non Proprietary Name: | MILRINONE LACTATE |
| Active Ingredient(s): | 200 ug/mL & nbsp; MILRINONE LACTATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0338-6010 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075834 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080602 |
| Package NDC: | 0338-6010-48 |
| Package Description: | 100 mL in 1 BAG (0338-6010-48) |
| NDC Code | 0338-6010-48 |
| Proprietary Name | Milrinone Lactate in Dextrose |
| Package Description | 100 mL in 1 BAG (0338-6010-48) |
| Product NDC | 0338-6010 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MILRINONE LACTATE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080602 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MILRINONE LACTATE |
| Strength Number | 200 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |